4//SEC Filing
CHALMERS DEREK T 4
Accession 0001209191-21-053534
CIK 0001346830other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:14 PM ET
Size
5.5 KB
Accession
0001209191-21-053534
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Award
Common Stock
2021-08-24+17,334→ 1,019,845 total
Footnotes (1)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on August 24, 2021. The vested shares represents the first of three possible vesting events of the total number of shares subject to the award. The remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001166287
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 6:14 PM ET
- Size
- 5.5 KB